Reviewing treatment outcomes of tuberculosis patients at Zagazig Chest Hospital (2008–2012)
| Autor: | Ramadan M. Nafae, Ahmed Mohamed Said, Mona A. Ibrahim, Hanan M. El-Shahat |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
lcsh:RC705-779
Pediatrics medicine.medical_specialty Tuberculosis business.industry lcsh:Diseases of the respiratory system medicine.disease Middle age 03 medical and health sciences Regimen 0302 clinical medicine 030228 respiratory system Reviewing treatment Zagazig Chest hospital Radiological weapon Medicine Short course 030212 general & internal medicine Treatment outcome business Directly Observed Therapy Cohort study |
| Zdroj: | Egyptian Journal of Chest Disease and Tuberculosis, Vol 66, Iss 4, Pp 623-630 (2017) |
| ISSN: | 0422-7638 |
| Popis: | Background: Tuberculosis (TB) is one of major critical heath problem worldwide, where drug treatment is fundamental for controlling TB promoting cure of the patient and breaking the chain of transmission when treatment is completely and correctly followed. Aim of the study: Aim of the study is to assess the treatment outcomes of TB patients at Zagazig Chest Hospital and to identify factors associated with poor outcomes in a trial to achieve the national tuberculosis program (NTP) goals. Patients and methods: This is a cohort study that was carried out at Zagazig Chest Hospital which was in part retrospective and prospective in other part. Analysis of data of 290 tuberculous patients was done where 10 cases were excluded. Demographic, socioeconomic data were reported in addition to radiological, bacteriologic histopathological diagnostic data and history of previous treatment of TB and the used anti-tuberculous treatment regimens with application of directly observed therapy short course (DOTS) strategy. Treatment outcomes were assessed for all patients and were classified either as successful or unsuccessful. Results: Successful treatment outcome was reported in 231 (82.5%) TB cases versus 49 (17.5%) cases with unsuccessful treatment. Successful outcome was significantly associated with middle age (16–35 years) (51.5%) (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|